1. Home
  2. MSGM vs BCDA Comparison

MSGM vs BCDA Comparison

Compare MSGM & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorsport Games Inc.

MSGM

Motorsport Games Inc.

HOLD

Current Price

$4.51

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

BCDA

BioCardia Inc.

HOLD

Current Price

$1.02

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSGM
BCDA
Founded
2018
N/A
Country
United States
United States
Employees
N/A
21
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
12.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MSGM
BCDA
Price
$4.51
$1.02
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
58.5K
124.4K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
252.13
N/A
EPS
0.06
N/A
Revenue
$741,000.00
N/A
Revenue This Year
$69.73
N/A
Revenue Next Year
$146.81
N/A
P/E Ratio
$74.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$1.00
52 Week High
$5.78
$2.49

Technical Indicators

Market Signals
Indicator
MSGM
BCDA
Relative Strength Index (RSI) 51.57 34.39
Support Level $3.64 $1.00
Resistance Level $4.57 $1.30
Average True Range (ATR) 0.36 0.06
MACD 0.01 -0.01
Stochastic Oscillator 35.21 11.68

Price Performance

Historical Comparison
MSGM
BCDA

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: